Randomised clinical trials in critical care: past, present and future.
Anders Granholm,Waleed Alhazzani,Lennie P. G. Derde,Lennie P. G. Derde,Derek C. Angus,Fernando G. Zampieri,Naomi E Hammond,Naomi E Hammond,Rob Mac Sweeney,Sheila Nainan Myatra,Elie Azoulay,Kathryn M Rowan,Paul J Young,Anders Perner,Morten Hylander Møller +14 more
Reads0
Chats0
TLDR
In this article, the authors provide an overview of the history of RCT and discuss the major challenges and limitations of current critical care RCTs, including overly optimistic effect sizes; unnuanced conclusions based on dichotomization of results; limited focus on patient-centred outcomes other than mortality; lack of flexibility and ability to adapt, increasing the risk of inconclusive results and limiting knowledge gains before trial completion; and inefficiency due to lack of re-use of trial infrastructure.Abstract:
Randomised clinical trials (RCTs) are the gold standard for providing unbiased evidence of intervention effects. Here, we provide an overview of the history of RCTs and discuss the major challenges and limitations of current critical care RCTs, including overly optimistic effect sizes; unnuanced conclusions based on dichotomization of results; limited focus on patient-centred outcomes other than mortality; lack of flexibility and ability to adapt, increasing the risk of inconclusive results and limiting knowledge gains before trial completion; and inefficiency due to lack of re-use of trial infrastructure. We discuss recent developments in critical care RCTs and novel methods that may provide solutions to some of these challenges, including a research programme approach (consecutive, complementary studies of multiple types rather than individual, independent studies), and novel design and analysis methods. These include standardization of trial protocols; alternative outcome choices and use of core outcome sets; increased acceptance of uncertainty, probabilistic interpretations and use of Bayesian statistics; novel approaches to assessing heterogeneity of treatment effects; adaptation and platform trials; and increased integration between clinical trials and clinical practice. We outline the advantages and discuss the potential methodological and practical disadvantages with these approaches. With this review, we aim to inform clinicians and researchers about conventional and novel RCTs, including the rationale for choosing one or the other methodological approach based on a thorough discussion of pros and cons. Importantly, the most central feature remains the randomisation, which provides unparalleled restriction of confounding compared to non-randomised designs by reducing confounding to chance.read more
Citations
More filters
Journal ArticleDOI
Extracorporeal Membrane Oxygenation during Respiratory Pandemics: Past, Present, and Future
TL;DR: The role of extracorporeal membrane oxygenation (ECMO) in the management of severe acute respiratory failure, including acute respiratory distress syndrome, has become better defined in recent years in light of emerging high-quality evidence and technological advances as discussed by the authors .
Journal ArticleDOI
Sepsis subphenotyping based on organ dysfunction trajectory
TL;DR: In this paper , the authors used dynamic time warping (DTW) to compute heterogeneous SOFA trajectory similarities and hierarchical agglomerative clustering (HAC) to identify trajectory-based subphenotypes.
Journal ArticleDOI
Heterogeneous treatment effects of dexamethasone 12 mg versus 6 mg in patients with COVID‐19 and severe hypoxaemia—Post hoc exploratory analyses of the COVID STEROID 2 trial
Anders Granholm,Marie Warrer Munch,Nina Christine Andersen-Ranberg,Sheila Nainan Myatra,Bharath Kumar Tirupakuzhi Vijayaraghavan,Balasubramanian Venkatesh,Vivekanand Jha,Rebecka Wahlin Rubenson,Stephan M. Jakob,Luca Cioccari,Morten Hylander Møller,Anders Perner +11 more
TL;DR: In this article , Corticosteroids improve outcomes in patients with severe COVID 19 in COVID StEROID 2 randomised clinical trial, and high probabilities of benefit with dexamethasone 12 versus 6 mg daily.
Journal ArticleDOI
Interactions in the 2×2×2 factorial randomised clinical STEPCARE trial and the potential effects on conclusions: a protocol for a simulation study
Markus Harboe Olsen,Aksel Karl Georg Jensen,Josef Dankiewicz,Markus B. Skrifvars,Matti Reinikainen,Marjaana Tiainen,M Saxena,Anders Aneman,Christian Gluud,Susann Ullén,Niklas Nielsen,Janus Christian Jakobsen +11 more
TL;DR: In this article , the authors present a protocol for a simulation study investigating the consequences of different levels of interactions between the trial interventions on outcomes for the future 2×2×2 factorial designed randomised clinical Sedation, TEmperature, and Pressure after Cardiac Arrest and REsuscitation (STEPCARE) trial in comatose patients after out-of-hospital cardiac arrest.
Journal ArticleDOI
Emerging clinical trial designs may accelerate translation in hematology: lessons from COVID-19
TL;DR: The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the COVID-19 pandemic in 2020 created unprecedented global challenges to existing models of evidence evaluation and the RCT has taken its place as the gold standard for establishing causation in clinical research.
References
More filters
Journal ArticleDOI
Dexamethasone in Hospitalized Patients with Covid-19
Peter Horby,Wei Shen Lim,Jonathan Emberson,M Mafham,Jennifer L Bell,Louise Linsell,Natalie Staplin,Christopher E. Brightling,Andrew Ustianowski,E Elmahi,B Prudon,Christopher A Green,Timothy Felton,David Chadwick,K Rege,C Fegan,Lucy C Chappell,Saul N. Faust,Thomas Jaki,Katie Jeffery,Alan A Montgomery,Kathryn M Rowan,Edmund Juszczak,J K Baillie,Richard Haynes,Martin J Landray +25 more
TL;DR: In patients hospitalized with Covid-19, the use of dexamethasone resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomization but not among those receiving no respiratory support.
Journal ArticleDOI
The ASA's Statement on p-Values: Context, Process, and Purpose
TL;DR: The American Statistical Association (ASA) released a policy statement on p-values and statistical significance in 2015 as discussed by the authors, which was based on a discussion with the ASA Board of Trustees and concerned with reproducibility and replicability of scientific conclusions.
Journal ArticleDOI
From best evidence to best practice: effective implementation of change in patients' care
Richard Grol,Jeremy M. Grimshaw +1 more
TL;DR: In this article, the authors provide an overview of present knowledge about initiatives to changing medical practice and suggest that to change behaviour is possible, but this change generally requires comprehensive approaches at different levels (doctor, team practice, hospital, wider environment), tailored to specific settings and target groups.
Journal ArticleDOI
A comparison of albumin and saline for fluid resuscitation in the intensive care unit
TL;DR: In patients in the ICU, use of either 4 percent albumin or normal saline for fluid resuscitation results in similar outcomes at 28 days, with no significant differences between the groups.
Journal ArticleDOI
The cost of dichotomising continuous variables
TL;DR: The impact of converting continuous data to two groups (dichotomising) is considered, as this is the most common approach in clinical research.